Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
| UnnamedSample_HQ_transcript/55202|m.15076 | UnnamedSample_HQ_transcript/55202 | Coverage 0.276 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00581 | Rhodanese-like domain | 30 | 142 | 2.7E-8 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/45753|m.13088 | UnnamedSample_HQ_transcript/45753 | Coverage 0.246 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 235 | 366 | 3.4E-38 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/45753|m.13088 | UnnamedSample_HQ_transcript/45753 | Coverage 0.246 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00581 | Rhodanese-like domain | 30 | 142 | 2.7E-8 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/56226|m.15286 | UnnamedSample_HQ_transcript/56226 | Coverage 0.283 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 235 | 366 | 3.4E-38 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/56226|m.15286 | UnnamedSample_HQ_transcript/56226 | Coverage 0.283 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00581 | Rhodanese-like domain | 30 | 142 | 2.7E-8 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/48196|m.13622 | UnnamedSample_HQ_transcript/48196 | Coverage 0.258 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 235 | 366 | 3.4E-38 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/48196|m.13622 | UnnamedSample_HQ_transcript/48196 | Coverage 0.258 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00581 | Rhodanese-like domain | 30 | 142 | 2.7E-8 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/42725|m.12425 | UnnamedSample_HQ_transcript/42725 | Coverage 0.238 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 235 | 366 | 3.4E-38 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/42725|m.12425 | UnnamedSample_HQ_transcript/42725 | Coverage 0.238 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00581 | Rhodanese-like domain | 30 | 142 | 2.7E-8 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/50202|m.14060 | UnnamedSample_HQ_transcript/50202 | Coverage 0.266 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 235 | 366 | 3.4E-38 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/50202|m.14060 | UnnamedSample_HQ_transcript/50202 | Coverage 0.266 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00581 | Rhodanese-like domain | 30 | 142 | 2.7E-8 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/15819|m.5650 | UnnamedSample_HQ_transcript/15819 | Coverage 0.168 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 235 | 366 | 3.4E-38 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/15819|m.5650 | UnnamedSample_HQ_transcript/15819 | Coverage 0.168 too low. | 8aa06083801ac666cabcedc40f3be04f | 452 | Pfam | PF00581 | Rhodanese-like domain | 30 | 142 | 2.7E-8 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/40604|m.11980 | UnnamedSample_HQ_transcript/40604 | Coverage 0.182 too low. | ae20bfc4b674c9bfd7af3891a620f7c2 | 722 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 573 | 607 | 1.7E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/40604|m.11980 | UnnamedSample_HQ_transcript/40604 | Coverage 0.182 too low. | ae20bfc4b674c9bfd7af3891a620f7c2 | 722 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 531 | 565 | 3.1E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/40604|m.11980 | UnnamedSample_HQ_transcript/40604 | Coverage 0.182 too low. | ae20bfc4b674c9bfd7af3891a620f7c2 | 722 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 326 | 362 | 4.8E-6 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/40604|m.11980 | UnnamedSample_HQ_transcript/40604 | Coverage 0.182 too low. | ae20bfc4b674c9bfd7af3891a620f7c2 | 722 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 616 | 650 | 9.7E-7 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/22114|m.7462 | UnnamedSample_HQ_transcript/22114 | Coverage 0.355 too low. | 603c71d87fac42f7bd9371f4f51f6ef5 | 804 | Pfam | PF00400 | WD domain, G-beta repeat | 639 | 674 | 0.05 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/22114|m.7462 | UnnamedSample_HQ_transcript/22114 | Coverage 0.355 too low. | 603c71d87fac42f7bd9371f4f51f6ef5 | 804 | Pfam | PF00400 | WD domain, G-beta repeat | 686 | 721 | 0.0037 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/22114|m.7462 | UnnamedSample_HQ_transcript/22114 | Coverage 0.355 too low. | 603c71d87fac42f7bd9371f4f51f6ef5 | 804 | Pfam | PF00400 | WD domain, G-beta repeat | 279 | 324 | 2.2E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/22114|m.7462 | UnnamedSample_HQ_transcript/22114 | Coverage 0.355 too low. | 603c71d87fac42f7bd9371f4f51f6ef5 | 804 | Pfam | PF03451 | HELP motif | 203 | 275 | 1.1E-31 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/68946|m.17753 | UnnamedSample_HQ_transcript/68946 | Coverage 0.046 too low. | 163b388cfc9890decba38ec2260e875a | 214 | Pfam | PF00071 | Ras family | 13 | 173 | 3.2E-63 | T | 22-09-2020 | IPR001806 | Small GTPase |
| UnnamedSample_HQ_transcript/57523|m.15552 | UnnamedSample_HQ_transcript/57523 | Coverage 0.979 too low. | 4a4de3064c076295c1dde91b55fcc060 | 593 | Pfam | PF01429 | Methyl-CpG binding domain | 438 | 500 | 1.3E-8 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/98605|m.22446 | UnnamedSample_HQ_transcript/98605 | Coverage 0.990 too low. | cea6a8590e252602131e89e8ff9d9f4a | 176 | Pfam | PF10058 | Predicted integral membrane zinc-ribbon metal-binding protein | 2 | 44 | 3.8E-15 | T | 22-09-2020 | IPR019273 | Lunapark domain |
| UnnamedSample_HQ_transcript/86882|m.20780 | UnnamedSample_HQ_transcript/86882 | Coverage 0.828 too low. | 571fce2a91df2f0854cb9eb4bc55e232 | 191 | Pfam | PF04201 | Tumour protein D52 family | 33 | 165 | 1.8E-35 | T | 22-09-2020 | IPR007327 | Tumour protein D52 |
| UnnamedSample_HQ_transcript/96301|m.22140 | UnnamedSample_HQ_transcript/96301 | Coverage 0.931 too low. | 571fce2a91df2f0854cb9eb4bc55e232 | 191 | Pfam | PF04201 | Tumour protein D52 family | 33 | 165 | 1.8E-35 | T | 22-09-2020 | IPR007327 | Tumour protein D52 |
| UnnamedSample_HQ_transcript/82376|m.20092 | UnnamedSample_HQ_transcript/82376 | Coverage 0.840 too low. | 571fce2a91df2f0854cb9eb4bc55e232 | 191 | Pfam | PF04201 | Tumour protein D52 family | 33 | 165 | 1.8E-35 | T | 22-09-2020 | IPR007327 | Tumour protein D52 |
| UnnamedSample_HQ_transcript/91419|m.21461 | UnnamedSample_HQ_transcript/91419 | Coverage 0.919 too low. | 571fce2a91df2f0854cb9eb4bc55e232 | 191 | Pfam | PF04201 | Tumour protein D52 family | 33 | 165 | 1.8E-35 | T | 22-09-2020 | IPR007327 | Tumour protein D52 |
| UnnamedSample_HQ_transcript/60754|m.16210 | UnnamedSample_HQ_transcript/60754 | Identity 0.941 too low. | 5a68458720c059d229830cd53b113b13 | 233 | Pfam | PF05199 | GMC oxidoreductase | 72 | 216 | 7.5E-39 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/58196|m.15695 | UnnamedSample_HQ_transcript/58196 | Coverage 0.062 too low. | 4c17c1779c8de5e48da80027e8459018 | 618 | Pfam | PF07679 | Immunoglobulin I-set domain | 119 | 211 | 6.3E-20 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/58196|m.15695 | UnnamedSample_HQ_transcript/58196 | Coverage 0.062 too low. | 4c17c1779c8de5e48da80027e8459018 | 618 | Pfam | PF07679 | Immunoglobulin I-set domain | 223 | 316 | 3.2E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/58196|m.15695 | UnnamedSample_HQ_transcript/58196 | Coverage 0.062 too low. | 4c17c1779c8de5e48da80027e8459018 | 618 | Pfam | PF07679 | Immunoglobulin I-set domain | 9 | 102 | 3.9E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/58196|m.15695 | UnnamedSample_HQ_transcript/58196 | Coverage 0.062 too low. | 4c17c1779c8de5e48da80027e8459018 | 618 | Pfam | PF07679 | Immunoglobulin I-set domain | 425 | 512 | 1.9E-5 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/58196|m.15695 | UnnamedSample_HQ_transcript/58196 | Coverage 0.062 too low. | 4c17c1779c8de5e48da80027e8459018 | 618 | Pfam | PF07679 | Immunoglobulin I-set domain | 528 | 618 | 1.0E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/58196|m.15695 | UnnamedSample_HQ_transcript/58196 | Coverage 0.062 too low. | 4c17c1779c8de5e48da80027e8459018 | 618 | Pfam | PF07679 | Immunoglobulin I-set domain | 330 | 420 | 1.1E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/43783|m.12662 | UnnamedSample_HQ_transcript/43783 | Coverage 0.045 too low. | e1094a1e5ba86389d2fedcae7d585d1c | 778 | Pfam | PF16350 | FAD dependent oxidoreductase central domain | 398 | 452 | 1.9E-18 | T | 22-09-2020 | IPR032503 | FAD dependent oxidoreductase, central domain |
| UnnamedSample_HQ_transcript/43783|m.12662 | UnnamedSample_HQ_transcript/43783 | Coverage 0.045 too low. | e1094a1e5ba86389d2fedcae7d585d1c | 778 | Pfam | PF01571 | Aminomethyltransferase folate-binding domain | 457 | 764 | 6.0E-51 | T | 22-09-2020 | IPR006222 | Aminomethyltransferase, folate-binding domain |
| UnnamedSample_HQ_transcript/43783|m.12662 | UnnamedSample_HQ_transcript/43783 | Coverage 0.045 too low. | e1094a1e5ba86389d2fedcae7d585d1c | 778 | Pfam | PF01266 | FAD dependent oxidoreductase | 38 | 393 | 5.2E-65 | T | 22-09-2020 | IPR006076 | FAD dependent oxidoreductase |
| UnnamedSample_HQ_transcript/13356|m.4909 | UnnamedSample_HQ_transcript/13356 | Coverage 0.910 too low. | be4823c9574d5c8670507d3a19630954 | 699 | Pfam | PF07645 | Calcium-binding EGF domain | 537 | 566 | 7.9E-4 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/13356|m.4909 | UnnamedSample_HQ_transcript/13356 | Coverage 0.910 too low. | be4823c9574d5c8670507d3a19630954 | 699 | Pfam | PF07645 | Calcium-binding EGF domain | 485 | 519 | 3.2E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/13356|m.4909 | UnnamedSample_HQ_transcript/13356 | Coverage 0.910 too low. | be4823c9574d5c8670507d3a19630954 | 699 | Pfam | PF02412 | Thrombospondin type 3 repeat | 665 | 699 | 3.6E-11 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/3075|m.1470 | UnnamedSample_HQ_transcript/3075 | Coverage 0.242 too low. | 3ad718c16eef256cf0a82af26607cb1e | 1147 | Pfam | PF13246 | Cation transport ATPase (P-type) | 478 | 568 | 4.1E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3075|m.1470 | UnnamedSample_HQ_transcript/3075 | Coverage 0.242 too low. | 3ad718c16eef256cf0a82af26607cb1e | 1147 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 29 | 89 | 3.6E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/3075|m.1470 | UnnamedSample_HQ_transcript/3075 | Coverage 0.242 too low. | 3ad718c16eef256cf0a82af26607cb1e | 1147 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 815 | 1063 | 2.7E-74 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/30258|m.9538 | UnnamedSample_HQ_transcript/30258 | Coverage 0.312 too low. | f57a17a9150e77e62baf17de485947b0 | 273 | Pfam | PF01754 | A20-like zinc finger | 245 | 267 | 8.2E-8 | T | 22-09-2020 | IPR002653 | Zinc finger, A20-type |
| UnnamedSample_HQ_transcript/17824|m.6252 | UnnamedSample_HQ_transcript/17824 | Identity 0.901 too low. | b29a3ca2a9577b6f1f5317ad63bfc991 | 636 | Pfam | PF02864 | STAT protein, DNA binding domain | 232 | 364 | 1.6E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/17824|m.6252 | UnnamedSample_HQ_transcript/17824 | Identity 0.901 too low. | b29a3ca2a9577b6f1f5317ad63bfc991 | 636 | Pfam | PF00017 | SH2 domain | 484 | 562 | 1.2E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/17824|m.6252 | UnnamedSample_HQ_transcript/17824 | Identity 0.901 too low. | b29a3ca2a9577b6f1f5317ad63bfc991 | 636 | Pfam | PF01017 | STAT protein, all-alpha domain | 31 | 197 | 2.2E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/92804|m.21633 | UnnamedSample_HQ_transcript/92804 | Coverage 0.988 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF13174 | Tetratricopeptide repeat | 213 | 244 | 0.046 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/92804|m.21633 | UnnamedSample_HQ_transcript/92804 | Coverage 0.988 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF13181 | Tetratricopeptide repeat | 63 | 94 | 0.19 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/92804|m.21633 | UnnamedSample_HQ_transcript/92804 | Coverage 0.988 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF12895 | Anaphase-promoting complex, cyclosome, subunit 3 | 144 | 199 | 1.9E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/81852|m.20009 | UnnamedSample_HQ_transcript/81852 | Coverage 0.990 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF13174 | Tetratricopeptide repeat | 213 | 244 | 0.046 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/81852|m.20009 | UnnamedSample_HQ_transcript/81852 | Coverage 0.990 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF13181 | Tetratricopeptide repeat | 63 | 94 | 0.19 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/81852|m.20009 | UnnamedSample_HQ_transcript/81852 | Coverage 0.990 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF12895 | Anaphase-promoting complex, cyclosome, subunit 3 | 144 | 199 | 1.9E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/86618|m.20742 | UnnamedSample_HQ_transcript/86618 | Coverage 0.990 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF13174 | Tetratricopeptide repeat | 213 | 244 | 0.046 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/86618|m.20742 | UnnamedSample_HQ_transcript/86618 | Coverage 0.990 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF13181 | Tetratricopeptide repeat | 63 | 94 | 0.19 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/86618|m.20742 | UnnamedSample_HQ_transcript/86618 | Coverage 0.990 too low. | 38b81ca9220e77876f942568b507478a | 258 | Pfam | PF12895 | Anaphase-promoting complex, cyclosome, subunit 3 | 144 | 199 | 1.9E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/35584|m.10835 | UnnamedSample_HQ_transcript/35584 | Coverage 0.829 too low. | e5ff29c35df706557841e9e57cf1f51d | 703 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 107 | 158 | 2.9E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/35584|m.10835 | UnnamedSample_HQ_transcript/35584 | Coverage 0.829 too low. | e5ff29c35df706557841e9e57cf1f51d | 703 | Pfam | PF14598 | PAS domain | 372 | 476 | 9.5E-22 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/35584|m.10835 | UnnamedSample_HQ_transcript/35584 | Coverage 0.829 too low. | e5ff29c35df706557841e9e57cf1f51d | 703 | Pfam | PF00989 | PAS fold | 182 | 284 | 2.9E-10 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/23000|m.7692 | UnnamedSample_HQ_transcript/23000 | Coverage 0.401 too low. | 952c8e66f7623c9e57a4df39a15e2285 | 357 | Pfam | PF00651 | BTB/POZ domain | 61 | 160 | 1.1E-25 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/86972|m.20800 | UnnamedSample_HQ_transcript/86972 | Coverage 0.077 too low. | 952c8e66f7623c9e57a4df39a15e2285 | 357 | Pfam | PF00651 | BTB/POZ domain | 61 | 160 | 1.1E-25 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/181|m.165 | UnnamedSample_HQ_transcript/181 | Unmapped. | a23ca94b183be334090ea00e071169ac | 996 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 417 | 671 | 4.5E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF15410 | Pleckstrin homology domain | 2245 | 2349 | 3.2E-15 | T | 22-09-2020 | IPR041681 | Pleckstrin homology domain 9 |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 954 | 1057 | 5.8E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 299 | 407 | 3.9E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 419 | 520 | 1.3E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1060 | 1166 | 6.8E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 742 | 843 | 1.4E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 636 | 738 | 6.5E-25 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1487 | 1589 | 1.1E-20 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1699 | 1801 | 5.7E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1912 | 2014 | 2.6E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1594 | 1696 | 8.5E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1386 | 1483 | 1.1E-15 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 524 | 633 | 8.7E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 848 | 949 | 1.7E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 2019 | 2106 | 4.9E-11 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1276 | 1376 | 2.2E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1806 | 1908 | 6.8E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00435 | Spectrin repeat | 1170 | 1266 | 2.8E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00307 | Calponin homology (CH) domain | 169 | 273 | 3.4E-26 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/212|m.189 | UnnamedSample_HQ_transcript/212 | Coverage 0.960 too low. | 7ae70a5bee2e4ebe623e1cb866162ed2 | 2389 | Pfam | PF00307 | Calponin homology (CH) domain | 49 | 152 | 1.2E-19 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/24740|m.8149 | UnnamedSample_HQ_transcript/24740 | Coverage 0.857 too low. | a07ec2eec8da3aef8d9e952370449d73 | 849 | Pfam | PF00089 | Trypsin | 610 | 843 | 2.5E-57 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/21210|m.7203 | UnnamedSample_HQ_transcript/21210 | Coverage 0.845 too low. | a07ec2eec8da3aef8d9e952370449d73 | 849 | Pfam | PF00089 | Trypsin | 610 | 843 | 2.5E-57 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/17870|m.6262 | UnnamedSample_HQ_transcript/17870 | Identity 0.901 too low. | b852414efa77ef443e2a9bf1bffda253 | 474 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 225 | 461 | 4.6E-76 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/97642|m.22319 | UnnamedSample_HQ_transcript/97642 | Coverage 0.984 too low. | fbadecf7f0c7604f245449bb131aa48c | 347 | Pfam | PF01846 | FF domain | 296 | 345 | 9.8E-12 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/97642|m.22319 | UnnamedSample_HQ_transcript/97642 | Coverage 0.984 too low. | fbadecf7f0c7604f245449bb131aa48c | 347 | Pfam | PF00397 | WW domain | 126 | 153 | 1.8E-10 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/97642|m.22319 | UnnamedSample_HQ_transcript/97642 | Coverage 0.984 too low. | fbadecf7f0c7604f245449bb131aa48c | 347 | Pfam | PF00397 | WW domain | 167 | 194 | 1.2E-9 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/106684|m.23413 | UnnamedSample_HQ_transcript/106684 | Coverage 0.988 too low. | ab229e07c67ab597ffd37ecfa53446c6 | 249 | Pfam | PF15996 | Arginine/serine-rich protein PNISR | 229 | 249 | 5.7E-8 | T | 22-09-2020 | IPR031937 | PNN-interacting serine/arginine-rich protein |
| UnnamedSample_HQ_transcript/4585|m.2031 | UnnamedSample_HQ_transcript/4585 | Coverage 0.924 too low. | 5f3a61806b7cb73bd2d71562b099c7af | 342 | Pfam | PF00083 | Sugar (and other) transporter | 1 | 302 | 7.6E-61 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/42536|m.12381 | UnnamedSample_HQ_transcript/42536 | Coverage 0.831 too low. | 5f3a61806b7cb73bd2d71562b099c7af | 342 | Pfam | PF00083 | Sugar (and other) transporter | 1 | 302 | 7.6E-61 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/1785|m.971 | UnnamedSample_HQ_transcript/1785 | Coverage 0.907 too low. | c693249881fd466e36348ad2950d9190 | 1754 | Pfam | PF00109 | Beta-ketoacyl synthase, N-terminal domain | 27 | 264 | 8.6E-69 | T | 22-09-2020 | IPR014030 | Beta-ketoacyl synthase, N-terminal |
| UnnamedSample_HQ_transcript/1785|m.971 | UnnamedSample_HQ_transcript/1785 | Coverage 0.907 too low. | c693249881fd466e36348ad2950d9190 | 1754 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 387 | 496 | 1.5E-36 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/1785|m.971 | UnnamedSample_HQ_transcript/1785 | Coverage 0.907 too low. | c693249881fd466e36348ad2950d9190 | 1754 | Pfam | PF00698 | Acyl transferase domain | 516 | 830 | 5.9E-86 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/1785|m.971 | UnnamedSample_HQ_transcript/1785 | Coverage 0.907 too low. | c693249881fd466e36348ad2950d9190 | 1754 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 268 | 384 | 6.6E-40 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/1785|m.971 | UnnamedSample_HQ_transcript/1785 | Coverage 0.907 too low. | c693249881fd466e36348ad2950d9190 | 1754 | Pfam | PF14765 | Polyketide synthase dehydratase | 882 | 1078 | 4.5E-11 | T | 22-09-2020 | IPR020807 | Polyketide synthase, dehydratase domain |
| UnnamedSample_HQ_transcript/1785|m.971 | UnnamedSample_HQ_transcript/1785 | Coverage 0.907 too low. | c693249881fd466e36348ad2950d9190 | 1754 | Pfam | PF00107 | Zinc-binding dehydrogenase | 1577 | 1696 | 9.6E-19 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/62507|m.16540 | UnnamedSample_HQ_transcript/62507 | Coverage 0.875 too low. | aed9bd987dfea3935a315970e5e0bc76 | 491 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 40 | 126 | 5.3E-13 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/62507|m.16540 | UnnamedSample_HQ_transcript/62507 | Coverage 0.875 too low. | aed9bd987dfea3935a315970e5e0bc76 | 491 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 422 | 477 | 2.0E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/4810|m.2120 | UnnamedSample_HQ_transcript/4810 | Coverage 0.775 too low. | 60778455d8b5bbabb40f5e9248fabeb2 | 603 | Pfam | PF00178 | Ets-domain | 506 | 586 | 3.3E-34 | T | 22-09-2020 | IPR000418 | Ets domain |
| UnnamedSample_HQ_transcript/16187|m.5764 | UnnamedSample_HQ_transcript/16187 | Coverage 0.691 too low. | 464612ccc1e949717a090331dc2a9569 | 997 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 783 | 990 | 5.4E-73 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
| UnnamedSample_HQ_transcript/16187|m.5764 | UnnamedSample_HQ_transcript/16187 | Coverage 0.691 too low. | 464612ccc1e949717a090331dc2a9569 | 997 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 565 | 701 | 9.9E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/16187|m.5764 | UnnamedSample_HQ_transcript/16187 | Coverage 0.691 too low. | 464612ccc1e949717a090331dc2a9569 | 997 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 130 | 414 | 2.0E-33 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/14089|m.5133 | UnnamedSample_HQ_transcript/14089 | Coverage 0.678 too low. | 464612ccc1e949717a090331dc2a9569 | 997 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 783 | 990 | 5.4E-73 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
| UnnamedSample_HQ_transcript/14089|m.5133 | UnnamedSample_HQ_transcript/14089 | Coverage 0.678 too low. | 464612ccc1e949717a090331dc2a9569 | 997 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 565 | 701 | 9.9E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/14089|m.5133 | UnnamedSample_HQ_transcript/14089 | Coverage 0.678 too low. | 464612ccc1e949717a090331dc2a9569 | 997 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 130 | 414 | 2.0E-33 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/63291|m.16691 | UnnamedSample_HQ_transcript/63291 | Coverage 0.767 too low. | 5bd4d18b8a768e29f4811c707c312bc4 | 394 | Pfam | PF00412 | LIM domain | 149 | 204 | 1.0E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/83959|m.20332 | UnnamedSample_HQ_transcript/83959 | Coverage 0.861 too low. | ee0727d8ef393aede94a05a94679be0d | 453 | Pfam | PF00083 | Sugar (and other) transporter | 19 | 448 | 5.4E-48 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/73850|m.18622 | UnnamedSample_HQ_transcript/73850 | Coverage 0.757 too low. | ee0727d8ef393aede94a05a94679be0d | 453 | Pfam | PF00083 | Sugar (and other) transporter | 19 | 448 | 5.4E-48 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/68187|m.17617 | UnnamedSample_HQ_transcript/68187 | Coverage 0.727 too low. | ee0727d8ef393aede94a05a94679be0d | 453 | Pfam | PF00083 | Sugar (and other) transporter | 19 | 448 | 5.4E-48 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/110310|m.23874 | UnnamedSample_HQ_transcript/110310 | Coverage 0.919 too low. | 200d8d11236b9c5f0afa17ca213857f4 | 246 | Pfam | PF03098 | Animal haem peroxidase | 18 | 212 | 7.4E-68 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/27091|m.8741 | UnnamedSample_HQ_transcript/27091 | Coverage 0.528 too low. | d596861b21da306c30763c0fc9966b4e | 808 | Pfam | PF04959 | Arsenite-resistance protein 2 | 596 | 791 | 6.7E-54 | T | 22-09-2020 | IPR007042 | SERRATE/Ars2 , C-terminal |
| UnnamedSample_HQ_transcript/27091|m.8741 | UnnamedSample_HQ_transcript/27091 | Coverage 0.528 too low. | d596861b21da306c30763c0fc9966b4e | 808 | Pfam | PF12066 | SERRATE/Ars2, N-terminal domain | 136 | 245 | 3.7E-36 | T | 22-09-2020 | IPR021933 | SERRATE/Ars2, N-terminal |
| UnnamedSample_HQ_transcript/37552|m.11291 | UnnamedSample_HQ_transcript/37552 | Coverage 0.488 too low. | 31c1df2c1d8aa4fcbf5e51dd56296735 | 583 | Pfam | PF00757 | Furin-like cysteine rich region | 306 | 456 | 7.8E-26 | T | 22-09-2020 | IPR006211 | Furin-like cysteine-rich domain |
| UnnamedSample_HQ_transcript/37552|m.11291 | UnnamedSample_HQ_transcript/37552 | Coverage 0.488 too low. | 31c1df2c1d8aa4fcbf5e51dd56296735 | 583 | Pfam | PF01030 | Receptor L domain | 472 | 579 | 3.5E-25 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/37552|m.11291 | UnnamedSample_HQ_transcript/37552 | Coverage 0.488 too low. | 31c1df2c1d8aa4fcbf5e51dd56296735 | 583 | Pfam | PF01030 | Receptor L domain | 166 | 277 | 6.5E-27 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/20623|m.7040 | UnnamedSample_HQ_transcript/20623 | Identity 0.695 too low. | 5e8b78ffb3150ff5036880ba1bc10460 | 693 | Pfam | PF00780 | CNH domain | 386 | 663 | 3.7E-62 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/24287|m.8019 | UnnamedSample_HQ_transcript/24287 | Identity 0.819 too low. | 8661b6af7acca6b3419692aeacf91d84 | 696 | Pfam | PF01576 | Myosin tail | 2 | 691 | 7.2E-100 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/10522|m.3996 | UnnamedSample_HQ_transcript/10522 | Identity 0.913 too low. | 04afa5a9ab54e3971f213b9fb7a10c10 | 1173 | Pfam | PF00567 | Tudor domain | 639 | 749 | 8.9E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/10522|m.3996 | UnnamedSample_HQ_transcript/10522 | Identity 0.913 too low. | 04afa5a9ab54e3971f213b9fb7a10c10 | 1173 | Pfam | PF00567 | Tudor domain | 1049 | 1129 | 1.8E-10 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/10522|m.3996 | UnnamedSample_HQ_transcript/10522 | Identity 0.913 too low. | 04afa5a9ab54e3971f213b9fb7a10c10 | 1173 | Pfam | PF00567 | Tudor domain | 846 | 954 | 1.1E-13 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/10522|m.3996 | UnnamedSample_HQ_transcript/10522 | Identity 0.913 too low. | 04afa5a9ab54e3971f213b9fb7a10c10 | 1173 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 47 | 110 | 2.3E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/119489|m.24811 | UnnamedSample_HQ_transcript/119489 | Coverage 0.988 too low. | 80eb39e5dd7276df42df7522970f14bc | 138 | Pfam | PF05348 | Proteasome maturation factor UMP1 | 38 | 137 | 1.1E-24 | T | 22-09-2020 | IPR008012 | Proteasome maturation factor Ump1 |
| UnnamedSample_HQ_transcript/4755|m.2094 | UnnamedSample_HQ_transcript/4755 | Coverage 0.074 too low. | 2f784493507f9f681d31d663c3e5e092 | 1168 | Pfam | PF00211 | Adenylate and Guanylate cyclase catalytic domain | 965 | 1157 | 1.7E-61 | T | 22-09-2020 | IPR001054 | Adenylyl cyclase class-3/4/guanylyl cyclase |
| UnnamedSample_HQ_transcript/4755|m.2094 | UnnamedSample_HQ_transcript/4755 | Coverage 0.074 too low. | 2f784493507f9f681d31d663c3e5e092 | 1168 | Pfam | PF00211 | Adenylate and Guanylate cyclase catalytic domain | 396 | 554 | 1.6E-58 | T | 22-09-2020 | IPR001054 | Adenylyl cyclase class-3/4/guanylyl cyclase |
| UnnamedSample_HQ_transcript/4755|m.2094 | UnnamedSample_HQ_transcript/4755 | Coverage 0.074 too low. | 2f784493507f9f681d31d663c3e5e092 | 1168 | Pfam | PF06327 | Domain of Unknown Function (DUF1053) | 619 | 675 | 4.1E-11 | T | 22-09-2020 | IPR009398 | Adenylate cyclase, conserved domain |
| UnnamedSample_HQ_transcript/4755|m.2094 | UnnamedSample_HQ_transcript/4755 | Coverage 0.074 too low. | 2f784493507f9f681d31d663c3e5e092 | 1168 | Pfam | PF16214 | Adenylyl cyclase N-terminal extracellular and transmembrane region | 154 | 393 | 3.4E-56 | T | 22-09-2020 | IPR032628 | Adenylate cyclase, N-terminal |
| UnnamedSample_HQ_transcript/102078|m.22875 | UnnamedSample_HQ_transcript/102078 | Coverage 0.743 too low. | 60058f59d367f1de37805fa640772adc | 215 | Pfam | PF00043 | Glutathione S-transferase, C-terminal domain | 125 | 188 | 9.2E-11 | T | 22-09-2020 | IPR004046 | Glutathione S-transferase, C-terminal |
| UnnamedSample_HQ_transcript/102078|m.22875 | UnnamedSample_HQ_transcript/102078 | Coverage 0.743 too low. | 60058f59d367f1de37805fa640772adc | 215 | Pfam | PF02798 | Glutathione S-transferase, N-terminal domain | 2 | 75 | 7.3E-14 | T | 22-09-2020 | IPR004045 | Glutathione S-transferase, N-terminal |
| UnnamedSample_HQ_transcript/4431|m.1969 | UnnamedSample_HQ_transcript/4431 | Coverage 0.890 too low. | 07ccdeb26e520308b97617c99b3a390b | 1039 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 297 | 373 | 5.2E-5 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/4431|m.1969 | UnnamedSample_HQ_transcript/4431 | Coverage 0.890 too low. | 07ccdeb26e520308b97617c99b3a390b | 1039 | Pfam | PF00620 | RhoGAP domain | 456 | 600 | 2.9E-32 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/91960|m.21533 | UnnamedSample_HQ_transcript/91960 | Coverage 0.535 too low. | 17ed46e2bebdf283c873df5efd66c579 | 353 | Pfam | PF00932 | Lamin Tail Domain | 213 | 318 | 5.7E-14 | T | 22-09-2020 | IPR001322 | Lamin tail domain |
| UnnamedSample_HQ_transcript/91960|m.21533 | UnnamedSample_HQ_transcript/91960 | Coverage 0.535 too low. | 17ed46e2bebdf283c873df5efd66c579 | 353 | Pfam | PF00038 | Intermediate filament protein | 24 | 169 | 1.4E-22 | T | 22-09-2020 | IPR039008 | Intermediate filament, rod domain |
| UnnamedSample_HQ_transcript/61662|m.16380 | UnnamedSample_HQ_transcript/61662 | Coverage 0.897 too low. | 669e1bffca68f989c4bb0a3aeeb97a0f | 320 | Pfam | PF03370 | Carbohydrate/starch-binding module (family 21) | 155 | 261 | 4.9E-32 | T | 22-09-2020 | IPR005036 | CBM21 (carbohydrate binding type-21) domain |
| UnnamedSample_HQ_transcript/41654|m.12192 | UnnamedSample_HQ_transcript/41654 | Coverage 0.868 too low. | 6feb3fa1ed47384c351381bea73e9baa | 437 | Pfam | PF00069 | Protein kinase domain | 168 | 416 | 6.1E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/59651|m.15990 | UnnamedSample_HQ_transcript/59651 | Coverage 0.737 too low. | 9fecb624c2fc50f6d612158043874d3a | 579 | Pfam | PF08790 | LYAR-type C2HC zinc finger | 35 | 62 | 1.1E-10 | T | 22-09-2020 | IPR014898 | Zinc finger, C2H2, LYAR-type |
| UnnamedSample_HQ_transcript/20272|m.6941 | UnnamedSample_HQ_transcript/20272 | Coverage 0.851 too low. | 9160f1857bea5aa1a955aff8dcf3cafd | 745 | Pfam | PF00098 | Zinc knuckle | 425 | 441 | 2.5E-4 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/20272|m.6941 | UnnamedSample_HQ_transcript/20272 | Coverage 0.851 too low. | 9160f1857bea5aa1a955aff8dcf3cafd | 745 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 187 | 296 | 1.5E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/35349|m.10788 | UnnamedSample_HQ_transcript/35349 | Coverage 0.200 too low. | fc7a0bafe1cedd83a9f4f2d73a4b6159 | 465 | Pfam | PF09457 | FIP domain | 427 | 461 | 2.8E-11 | T | 22-09-2020 | IPR019018 | Rab-binding domain FIP-RBD |
| UnnamedSample_HQ_transcript/1060|m.658 | UnnamedSample_HQ_transcript/1060 | Identity 0.909 too low. | 57ecb05a52840729479d5c70f409f76b | 1507 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 1375 | 1507 | 1.1E-41 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/1060|m.658 | UnnamedSample_HQ_transcript/1060 | Identity 0.909 too low. | 57ecb05a52840729479d5c70f409f76b | 1507 | Pfam | PF01833 | IPT/TIG domain | 983 | 1052 | 3.9E-10 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/1060|m.658 | UnnamedSample_HQ_transcript/1060 | Identity 0.909 too low. | 57ecb05a52840729479d5c70f409f76b | 1507 | Pfam | PF01833 | IPT/TIG domain | 890 | 979 | 4.2E-7 | T | 22-09-2020 | IPR002909 | IPT domain |
| UnnamedSample_HQ_transcript/1060|m.658 | UnnamedSample_HQ_transcript/1060 | Identity 0.909 too low. | 57ecb05a52840729479d5c70f409f76b | 1507 | Pfam | PF01403 | Sema domain | 50 | 367 | 1.1E-26 | T | 22-09-2020 | IPR001627 | Sema domain |
| UnnamedSample_HQ_transcript/47753|m.13524 | UnnamedSample_HQ_transcript/47753 | Coverage 0.655 too low. | 0e7af6882140ae76119e4c6986fe7b4f | 722 | Pfam | PF13041 | PPR repeat family | 204 | 250 | 5.0E-8 | T | 22-09-2020 | IPR002885 | Pentatricopeptide repeat |
| UnnamedSample_HQ_transcript/47753|m.13524 | UnnamedSample_HQ_transcript/47753 | Coverage 0.655 too low. | 0e7af6882140ae76119e4c6986fe7b4f | 722 | Pfam | PF13812 | Pentatricopeptide repeat domain | 125 | 180 | 1.1E-8 | T | 22-09-2020 | IPR002885 | Pentatricopeptide repeat |
| UnnamedSample_HQ_transcript/103515|m.23046 | UnnamedSample_HQ_transcript/103515 | Identity 0.703 too low. | 75b4915c1476edee215aa687bc5962bf | 314 | Pfam | PF00650 | CRAL/TRIO domain | 128 | 280 | 1.9E-36 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/14317|m.5201 | UnnamedSample_HQ_transcript/14317 | Coverage 0.236 too low. | ccb5cfd9225207bcf1806dd30106a4b3 | 692 | Pfam | PF02145 | Rap/ran-GAP | 259 | 439 | 5.3E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/63595|m.16754 | UnnamedSample_HQ_transcript/63595 | Coverage 0.687 too low. | c3e20d4365e28e243a312cd5f509649b | 408 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 2.8E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/4488|m.1994 | UnnamedSample_HQ_transcript/4488 | Coverage 0.282 too low. | 96dd16cdeabc6b5f97b7f7de872da2a0 | 589 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 291 | 588 | 2.2E-60 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/4488|m.1994 | UnnamedSample_HQ_transcript/4488 | Coverage 0.282 too low. | 96dd16cdeabc6b5f97b7f7de872da2a0 | 589 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 189 | 246 | 7.6E-23 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/76447|m.19103 | UnnamedSample_HQ_transcript/76447 | Identity 0.936 too low. | 2b9b87c82794126bb3a7ff17662e6dac | 187 | Pfam | PF01156 | Inosine-uridine preferring nucleoside hydrolase | 1 | 172 | 3.7E-25 | T | 22-09-2020 | IPR001910 | Inosine/uridine-preferring nucleoside hydrolase domain |
| UnnamedSample_HQ_transcript/77102|m.19218 | UnnamedSample_HQ_transcript/77102 | Coverage 0.870 too low. | 22af823559b8382e6079e46307404b81 | 390 | Pfam | PF00270 | DEAD/DEAH box helicase | 41 | 206 | 4.0E-45 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/77102|m.19218 | UnnamedSample_HQ_transcript/77102 | Coverage 0.870 too low. | 22af823559b8382e6079e46307404b81 | 390 | Pfam | PF00271 | Helicase conserved C-terminal domain | 243 | 351 | 2.0E-31 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/44252|m.12766 | UnnamedSample_HQ_transcript/44252 | Coverage 0.452 too low. | 22af823559b8382e6079e46307404b81 | 390 | Pfam | PF00270 | DEAD/DEAH box helicase | 41 | 206 | 4.0E-45 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/44252|m.12766 | UnnamedSample_HQ_transcript/44252 | Coverage 0.452 too low. | 22af823559b8382e6079e46307404b81 | 390 | Pfam | PF00271 | Helicase conserved C-terminal domain | 243 | 351 | 2.0E-31 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/98784|m.22466 | UnnamedSample_HQ_transcript/98784 | Coverage 0.950 too low. | 913524a7dee998e96652cea26d5592d3 | 296 | Pfam | PF01080 | Presenilin | 1 | 285 | 8.8E-116 | T | 22-09-2020 | IPR001108 | Peptidase A22A, presenilin |
| UnnamedSample_HQ_transcript/48719|m.13746 | UnnamedSample_HQ_transcript/48719 | Coverage 0.205 too low. | f9e283a760d054353af439b30c73d375 | 466 | Pfam | PF02793 | Hormone receptor domain | 33 | 92 | 7.3E-16 | T | 22-09-2020 | IPR001879 | GPCR, family 2, extracellular hormone receptor domain |
| UnnamedSample_HQ_transcript/48719|m.13746 | UnnamedSample_HQ_transcript/48719 | Coverage 0.205 too low. | f9e283a760d054353af439b30c73d375 | 466 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 102 | 346 | 4.3E-56 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/103108|m.23002 | UnnamedSample_HQ_transcript/103108 | Identity 0.906 too low. | 1e444bd6911a9120f18cb52dcf835720 | 175 | Pfam | PF02752 | Arrestin (or S-antigen), C-terminal domain | 3 | 105 | 5.6E-9 | T | 22-09-2020 | IPR011022 | Arrestin C-terminal-like domain |
| UnnamedSample_HQ_transcript/34281|m.10541 | UnnamedSample_HQ_transcript/34281 | Coverage 0.588 too low. | f15ffe735e0f65c26dace54d68099fd6 | 810 | Pfam | PF04389 | Peptidase family M28 | 221 | 414 | 2.3E-29 | T | 22-09-2020 | IPR007484 | Peptidase M28 |
| UnnamedSample_HQ_transcript/37895|m.11371 | UnnamedSample_HQ_transcript/37895 | Coverage 0.573 too low. | f15ffe735e0f65c26dace54d68099fd6 | 810 | Pfam | PF04389 | Peptidase family M28 | 221 | 414 | 2.3E-29 | T | 22-09-2020 | IPR007484 | Peptidase M28 |
| UnnamedSample_HQ_transcript/46369|m.13223 | UnnamedSample_HQ_transcript/46369 | Identity 0.843 too low. | 221d0fdb57378180e33e5e1fa04f9fdf | 599 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 467 | 576 | 2.8E-42 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/46369|m.13223 | UnnamedSample_HQ_transcript/46369 | Identity 0.843 too low. | 221d0fdb57378180e33e5e1fa04f9fdf | 599 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 357 | 462 | 8.1E-39 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/46369|m.13223 | UnnamedSample_HQ_transcript/46369 | Identity 0.843 too low. | 221d0fdb57378180e33e5e1fa04f9fdf | 599 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 39 | 93 | 2.7E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/46369|m.13223 | UnnamedSample_HQ_transcript/46369 | Identity 0.843 too low. | 221d0fdb57378180e33e5e1fa04f9fdf | 599 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 291 | 347 | 5.9E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/46369|m.13223 | UnnamedSample_HQ_transcript/46369 | Identity 0.843 too low. | 221d0fdb57378180e33e5e1fa04f9fdf | 599 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 78 | 136 | 2.7E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/80181|m.19743 | UnnamedSample_HQ_transcript/80181 | Unmapped. | bb5f971f3820885f094a52a22d6d3a99 | 224 | Pfam | PF10408 | Ubiquitin elongating factor core | 2 | 130 | 6.2E-45 | T | 22-09-2020 | IPR019474 | Ubiquitin conjugation factor E4, core |
| UnnamedSample_HQ_transcript/80181|m.19743 | UnnamedSample_HQ_transcript/80181 | Unmapped. | bb5f971f3820885f094a52a22d6d3a99 | 224 | Pfam | PF04564 | U-box domain | 147 | 218 | 4.0E-31 | T | 22-09-2020 | IPR003613 | U box domain |
| UnnamedSample_HQ_transcript/39108|m.11659 | UnnamedSample_HQ_transcript/39108 | Coverage 0.796 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF18694 | Transactive response DNA-binding protein N-terminal domain | 4 | 76 | 6.9E-31 | T | 22-09-2020 | IPR041105 | TAR DNA-binding protein 43, N-terminal |
| UnnamedSample_HQ_transcript/39108|m.11659 | UnnamedSample_HQ_transcript/39108 | Coverage 0.796 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 106 | 169 | 6.6E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/39108|m.11659 | UnnamedSample_HQ_transcript/39108 | Coverage 0.796 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 190 | 239 | 4.8E-10 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/46120|m.13168 | UnnamedSample_HQ_transcript/46120 | Coverage 0.896 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF18694 | Transactive response DNA-binding protein N-terminal domain | 4 | 76 | 6.9E-31 | T | 22-09-2020 | IPR041105 | TAR DNA-binding protein 43, N-terminal |
| UnnamedSample_HQ_transcript/46120|m.13168 | UnnamedSample_HQ_transcript/46120 | Coverage 0.896 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 106 | 169 | 6.6E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/46120|m.13168 | UnnamedSample_HQ_transcript/46120 | Coverage 0.896 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 190 | 239 | 4.8E-10 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/60649|m.16189 | UnnamedSample_HQ_transcript/60649 | Coverage 0.979 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF18694 | Transactive response DNA-binding protein N-terminal domain | 4 | 76 | 6.9E-31 | T | 22-09-2020 | IPR041105 | TAR DNA-binding protein 43, N-terminal |
| UnnamedSample_HQ_transcript/60649|m.16189 | UnnamedSample_HQ_transcript/60649 | Coverage 0.979 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 106 | 169 | 6.6E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/60649|m.16189 | UnnamedSample_HQ_transcript/60649 | Coverage 0.979 too low. | c9a1876b935b4efae66ce0a77703f119 | 419 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 190 | 239 | 4.8E-10 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/61858|m.16420 | UnnamedSample_HQ_transcript/61858 | Coverage 0.475 too low. | 09485639c9be06efadf4d6063cbe0eaa | 529 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 129 | 507 | 6.8E-96 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/10421|m.3964 | UnnamedSample_HQ_transcript/10421 | Coverage 0.586 too low. | 93f39ba00d62624afac6d67ad39cf1d3 | 977 | Pfam | PF02141 | DENN (AEX-3) domain | 633 | 822 | 7.2E-32 | T | 22-09-2020 | IPR001194 | cDENN domain |
| UnnamedSample_HQ_transcript/10421|m.3964 | UnnamedSample_HQ_transcript/10421 | Coverage 0.586 too low. | 93f39ba00d62624afac6d67ad39cf1d3 | 977 | Pfam | PF03456 | uDENN domain | 557 | 622 | 1.1E-6 | T | 22-09-2020 | IPR005113 | uDENN domain |
| UnnamedSample_HQ_transcript/88145|m.20957 | UnnamedSample_HQ_transcript/88145 | Coverage 0.186 too low. | 29525a3e68281af9c348d030e07d280a | 118 | Pfam | PF13639 | Ring finger domain | 2 | 44 | 2.9E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/105503|m.23285 | UnnamedSample_HQ_transcript/105503 | Unmapped. | ed7c4172f74a5bf01e9cca2560988820 | 315 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 1 | 313 | 1.7E-37 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/112596|m.24151 | UnnamedSample_HQ_transcript/112596 | Coverage 0.159 too low. | 2832c6f07536742872cd0f3b937a9ca7 | 262 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 175 | 224 | 2.2E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/112596|m.24151 | UnnamedSample_HQ_transcript/112596 | Coverage 0.159 too low. | 2832c6f07536742872cd0f3b937a9ca7 | 262 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 68 | 125 | 1.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/30059|m.9492 | UnnamedSample_HQ_transcript/30059 | Coverage 0.873 too low. | 421ec294bb89b9dcc4e288425d62c2fa | 492 | Pfam | PF01237 | Oxysterol-binding protein | 125 | 468 | 1.2E-79 | T | 22-09-2020 | IPR000648 | Oxysterol-binding protein |
| UnnamedSample_HQ_transcript/21280|m.7226 | UnnamedSample_HQ_transcript/21280 | Coverage 0.096 too low. | 119becd1d5e5ab420ac8fff139faf946 | 963 | Pfam | PF00400 | WD domain, G-beta repeat | 799 | 830 | 9.2E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21280|m.7226 | UnnamedSample_HQ_transcript/21280 | Coverage 0.096 too low. | 119becd1d5e5ab420ac8fff139faf946 | 963 | Pfam | PF00400 | WD domain, G-beta repeat | 749 | 784 | 0.069 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21280|m.7226 | UnnamedSample_HQ_transcript/21280 | Coverage 0.096 too low. | 119becd1d5e5ab420ac8fff139faf946 | 963 | Pfam | PF02138 | Beige/BEACH domain | 320 | 599 | 1.5E-121 | T | 22-09-2020 | IPR000409 | BEACH domain |
| UnnamedSample_HQ_transcript/21280|m.7226 | UnnamedSample_HQ_transcript/21280 | Coverage 0.096 too low. | 119becd1d5e5ab420ac8fff139faf946 | 963 | Pfam | PF16057 | Domain of unknown function (DUF4800) | 4 | 140 | 2.3E-37 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21280|m.7226 | UnnamedSample_HQ_transcript/21280 | Coverage 0.096 too low. | 119becd1d5e5ab420ac8fff139faf946 | 963 | Pfam | PF14844 | PH domain associated with Beige/BEACH | 209 | 293 | 1.8E-21 | T | 22-09-2020 | IPR023362 | PH-BEACH domain |
| UnnamedSample_HQ_transcript/70241|m.17965 | UnnamedSample_HQ_transcript/70241 | Coverage 0.963 too low. | cdea135ded90591635050d22db26fc7b | 324 | Pfam | PF00017 | SH2 domain | 132 | 209 | 9.1E-27 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/70241|m.17965 | UnnamedSample_HQ_transcript/70241 | Coverage 0.963 too low. | cdea135ded90591635050d22db26fc7b | 324 | Pfam | PF00018 | SH3 domain | 71 | 118 | 3.7E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/32863|m.10179 | UnnamedSample_HQ_transcript/32863 | Coverage 0.985 too low. | e892c84ebf8c06005786bc37c013eb3b | 268 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 2 | 243 | 2.6E-72 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/22918|m.7667 | UnnamedSample_HQ_transcript/22918 | Coverage 0.834 too low. | 11b48c24be176d22361cd0ac8d2ac07e | 928 | Pfam | PF12624 | N-terminal region of Chorein or VPS13 | 3 | 96 | 2.9E-18 | T | 22-09-2020 | IPR026854 | Vacuolar protein sorting-associated protein 13-like, N-terminal domain |
| UnnamedSample_HQ_transcript/65875|m.17183 | UnnamedSample_HQ_transcript/65875 | Coverage 0.990 too low. | c73d2887a287acd6cb2725f670366112 | 583 | Pfam | PF08145 | BOP1NT (NUC169) domain | 1 | 235 | 1.5E-89 | T | 22-09-2020 | IPR012953 | BOP1, N-terminal domain |
| UnnamedSample_HQ_transcript/65875|m.17183 | UnnamedSample_HQ_transcript/65875 | Coverage 0.990 too low. | c73d2887a287acd6cb2725f670366112 | 583 | Pfam | PF00400 | WD domain, G-beta repeat | 241 | 273 | 1.5E-8 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65875|m.17183 | UnnamedSample_HQ_transcript/65875 | Coverage 0.990 too low. | c73d2887a287acd6cb2725f670366112 | 583 | Pfam | PF00400 | WD domain, G-beta repeat | 492 | 523 | 0.23 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65875|m.17183 | UnnamedSample_HQ_transcript/65875 | Coverage 0.990 too low. | c73d2887a287acd6cb2725f670366112 | 583 | Pfam | PF00400 | WD domain, G-beta repeat | 549 | 582 | 0.0058 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/62248|m.16491 | UnnamedSample_HQ_transcript/62248 | Coverage 0.796 too low. | 6ef0792766ff2dbc16f306620d2f84cf | 376 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 183 | 346 | 1.8E-63 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
